(A) In vitro cellular uptake of HeLa cells incubated with free CUR, CUR-SPC NPs, PEG-CUR-SPC NPs and FA-PEG-CUR-SPC NPs examined by confocal laser scanning microscopy after 4 h incubation. Blue signal, DAPI; green signal, CUR. (B) Flow cytometry histogram profiles of HeLa cells incubated with free CUR, CUR-SPC NPs, PEG-CUR-SPC NPs and FA-PEG-CUR-SPC NPs for 4 h. (C) Quantitation of mean fluorescent intensity of free CUR, CUR-SPC NPs, PEG-CUR-SPC NPs and FA-PEG-CUR-SPC NPs in HeLa cells by flow cytometry. Data were presented as mean ± SD. (n = 3, *p < 0.05). (D, E) In vitro cell viability of HeLa cells incubated with free CUR, CUR-SPC NPs, PEG-CUR-SPC NPs and FA-PEG-CUR-SPC NPs at different concentrations (0.01, 0.05, 0.1, 0.5 and 1 mg/mL) for (D) 24 and (E) 48 h. (F, G) In vitro cell viability of Caco-2 cells incubated with drug-free CUR-SPC NPs and drug-free PEG-CUR-SPC NPs at different concentrations (0.01, 0.05, 0.1, 0.5 and 1 mg/mL) for (F) 24 and (G) 48 h.